Ali Moghani Lankarani, MD
Gastroenterology · Jacksonville, FLNPI 1215079256
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Olympus Corporation Of The Americas at 46.7% of the total. Reporting peaked in 2019 at $28,729 and has fallen 57.7% since, to $12,144 in 2025. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 537 payments — averaging $196.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$49K
- Sanofi$12K
- Micro-tech Endoscopy USA, Inc.$10K
- Covidien LP$10K
- Olympus America Inc.$9K
- Medtronic$6K
- plus $9K from 35 others
Across 40 payments — averaging $15,197 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$567K
- Regeneron$38K
- Roche Products Limited$3K
What the payments were for
- Consulting fees$27,19026%
- Speaking & faculty fees$14,89514%
- Travel & lodging$4,5134%
- Food & beverage$12,84112%
- Education$45,95344%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVIS EXERA$21,143
- Olympus EMR & ESD Devices$18,191
- Olympus EUS Devices$18,069
- Olympus Hemostasis Devices$18,069
- Olympus Capital Accessories$16,943
- ScopeGuide$16,943
- Olympus$10,695
- Olympus EndoTherapy Accessories$9,765
- All Products$9,350
- Olympus GI Stricture Devices$8,527
- Olympus GI Accessories$8,304
- Single Use Aspiration Needle NA-U200H$8,212
- VISIGLIDE$7,037
- Single Use Electrosurgical Knife KD-655$6,743
- DISPOSABLE DISTAL ATTACHMENT$6,632
- Single Use Biliary Stent V$5,250
- Olympus Endoscopic Ultrasound Scopes$4,642
- Olympus Bronchoscopes$4,200
- Olympus Duodenoscopes$4,200
- Olympus EBUS Bronchoscopes$4,200
How this compares
$105,392 in reported general payments places this provider in the 95th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 13 | $48,826 |
| LinzessLinaclotide | 29 | $28,585 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 54 | $3,416 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 18 | $3,098 |
| Omeprazole | 119 | $1,999 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 59 | $867 |
| Ondansetron HclOndansetron Hcl/Pf | 17 | $681 |
| Pantoprazole Sodium | 42 | $406 |
| Famotidine | 11 | $215 |
| Gabapentin | 12 | $148 |
| Levofloxacin | 20 | $42 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $40 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,141 | $77,41142 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $26 | $3,09818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Jacksonville
- Francis FarrayeJacksonville$395K
- Jami KinnucanJacksonville$313K
- Vivek KumbhariJacksonville$254K
- Ana CorregidorJacksonville$79K
- Mark FleisherJacksonville$74K
- Victoria GomezJacksonville$65K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.